A detailed history of Transcendent Capital Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transcendent Capital Group LLC holds 192 shares of BMY stock, worth $11,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares
192
Holding current value
$11,007
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $7,614 - $9,936
192 New
192 $9.93 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.